218 related articles for article (PubMed ID: 23560788)
1. [Bacterial isolates from respiratory samples of pediatric patients with cystic fibrosis and their distribution by ages].
Busquets NP; Baroni MR; Ochoteco MC; Zurbriggen ML; Virgolini S; Meneghetti FG
Rev Argent Microbiol; 2013; 45(1):44-9. PubMed ID: 23560788
[TBL] [Abstract][Full Text] [Related]
2. [The analysis of the isolated microorganisms from the respiratory tract of cystic fibrosis patients treated in Children's Memorial Health Institute 1999-2002].
Semczuk K; Dmeńska H; Dzierzanowska D; Kołodziejczyk M; Gabińska E; Zareba H
Pneumonol Alergol Pol; 2005; 73(1):41-7. PubMed ID: 16539183
[TBL] [Abstract][Full Text] [Related]
3. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
Anzaudo MM; Busquets NP; Ronchi S; Mayoral C
Rev Argent Microbiol; 2005; 37(3):129-34. PubMed ID: 16323660
[TBL] [Abstract][Full Text] [Related]
4. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
[TBL] [Abstract][Full Text] [Related]
6. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
[TBL] [Abstract][Full Text] [Related]
7. Microbiology of airway disease in a cohort of patients with cystic fibrosis.
Lambiase A; Raia V; Del Pezzo M; Sepe A; Carnovale V; Rossano F
BMC Infect Dis; 2006 Jan; 6():4. PubMed ID: 16405721
[TBL] [Abstract][Full Text] [Related]
8. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
Coman G; Petraru E; Dahorea C; Anton DT
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
[TBL] [Abstract][Full Text] [Related]
9. [Microbiological study of the respiratory tract in children with cystic fibrosis].
Muñoz C; Juncosa T; Gené A; Fortea J; Séculi JL; Latorre C
Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):142-4. PubMed ID: 8695681
[TBL] [Abstract][Full Text] [Related]
10. [Frequency of isolation and drug resistance of bacterial strains isolated from respiratory material in patients with cystic fibrosis].
Rosselli P
Quad Sclavo Diagn; 1986 Sep; 22(3):273-82. PubMed ID: 3112860
[TBL] [Abstract][Full Text] [Related]
11. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
[TBL] [Abstract][Full Text] [Related]
12. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
13. [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis].
Oliver A; Alarcón T; Caballero E; Cantón R
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):89-104. PubMed ID: 19232782
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial susceptibility of bacterial isolates from patients with cystic fibrosis].
García AD; Ibarra A; Rodríguez FC; Casal M
Rev Esp Quimioter; 2004 Dec; 17(4):332-5. PubMed ID: 15696223
[TBL] [Abstract][Full Text] [Related]
15. [Drug susceptibility of Haemophilus sp. and Staphylococcus aureus strains colonizing respiratory tract in children with mucoviscidosis].
Kosikowska U; Juda M; Malm A; Jóźwiakowska M; Tuszkiewicz-Misztal E
Przegl Epidemiol; 2007; 61(2):377-84. PubMed ID: 17956057
[TBL] [Abstract][Full Text] [Related]
16. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.
Valenza G; Tappe D; Turnwald D; Frosch M; König C; Hebestreit H; Abele-Horn M
J Cyst Fibros; 2008 Mar; 7(2):123-7. PubMed ID: 17693140
[TBL] [Abstract][Full Text] [Related]
18. [The composition and antimicrobial resistance of isolates from lower respiratory tract and blood in hospitalized patients in respiratory ward: a multicenter national study in China].
Tang X; Zhuo C; Xu YC; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Apr; 41(4):281-287. PubMed ID: 29690684
[No Abstract] [Full Text] [Related]
19. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
[TBL] [Abstract][Full Text] [Related]
20. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
Krzewinski JW; Nguyen CD; Foster JM; Burns JL
J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
